Correlation Between Body Mass Index and Periodontitis: A Clinical and Biochemical Analysis

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Jul 15

PMID 39006613

Authors

Johnisha Harris

Arvina Rajasekar

Affiliations

Soon will be listed here.

Abstract

Introduction Obesity is the excessive deposition of body fat in relation to lean body mass. In this research, its relation to periodontitis has been analysed using clinical and biochemical parameters. The current study assessed the correlation between body mass index (BMI) and periodontitis using salivary visfatin levels. Materials and methods Sixty participants (33 males and 27 females) were categorised into three different groups according to BMI: group 1: normal weight (n=20); group 2: overweight (n=20); and group 3: obese (n=20). Clinical parameters such as probing pocket depth (PPD) and clinical attachment level (CAL) were recorded. Salivary samples were collected and assessed for salivary visfatin levels with the aid of a human visfatin enzyme-linked immunosorbent assay (ELISA) kit. The results were assessed using IBM SPSS Statistics for Windows, Version 23.0 (Released 2015; IBM Corp., Armonk, New York, United States). Results The PPD, CAL, and salivary visfatin levels were higher in group 3, followed by groups 2 and 1, and were statistically significant (p=0.000). The correlation between visfatin and PPD (r=0.962) and visfatin and CAL (r=0.978) was strongly positive and statistically significant. Conclusion This study demonstrates a strong positive correlation between BMI and periodontitis. Moreover, salivary visfatin can be considered a diagnostic marker for periodontal diseases.

References

Wong L, Yap A, Allen P . Periodontal disease and quality of life: Umbrella review of systematic reviews. J Periodontal Res. 2020; 56(1):1-17. DOI: 10.1111/jre.12805. View

Kim C, Lee S, Hwang W, Son E, Kim T, Kim K . Obesity and periodontitis: A systematic review and updated meta-analysis. Front Endocrinol (Lausanne). 2022; 13:999455. PMC: 9637837. DOI: 10.3389/fendo.2022.999455. View

Abolfazli N, Jabali S, Saleh Saber F, Babaloo Z, Shirmohammadi A . Effect of Non-surgical Periodontal Therapy on Serum and Salivary Concentrations of Visfatin in Patients with Chronic Periodontitis. J Dent Res Dent Clin Dent Prospects. 2015; 9(1):11-7. PMC: 4417487. DOI: 10.15171/joddd.2015.003. View

Mopidevi A, Penmetsa G, Dwarkanath C, Dubba K, Gadde P . Salivary visfatin concentrations in patients with chronic periodontitis: An analysis before and after periodontal therapy. Indian J Dent Res. 2020; 30(6):864-869. DOI: 10.4103/ijdr.IJDR_673_17. View

Rajasekar A . Correlation of salivary visfatin levels in obese and NON-OBESE population with periodontal status. J Oral Biol Craniofac Res. 2022; 13(1):67-70. PMC: 9712686. DOI: 10.1016/j.jobcr.2022.11.004. View

Pradeep A, Raghavendra N, Sharma A, Patel S, Raju A, Kathariya R . Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. J Periodontol. 2011; 83(5):629-34. DOI: 10.1902/jop.2011.110272. View

Alizadeh Tabari Z, Keshani F, Sharbatdaran M, Banishahabadi A, Nejatifard M, Ghorbani H . Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dent Res J (Isfahan). 2018; 15(2):104-110. PMC: 5858068. View

Bayani M, Pourali M, Keivan M . Possible interaction between visfatin, periodontal infection, and other systemic diseases: A brief review of literature. Eur J Dent. 2017; 11(3):407-410. PMC: 5594975. DOI: 10.4103/ejd.ejd_284_16. View

Paul R, Suresh S, Sudhakar U, Jean C, Fernandez K . Evaluation of association between and visfatin levels in chronic periodontitis patients. J Indian Soc Periodontol. 2021; 24(6):530-534. PMC: 7781248. DOI: 10.4103/jisp.jisp_641_19. View

10.

Saseendran G, Abraham S, Nair A, Reejamol M . Comparative Evaluation of Salivary Visfatin Levels in Healthy and Periodontally Diseased Patients before and after Scaling and Root Planing. J Pharm Bioallied Sci. 2021; 13(Suppl 1):S624-S628. PMC: 8375887. DOI: 10.4103/jpbs.JPBS_546_20. View

11.

Goh V, Hassan F, Baharin B, Rosli T . Impact of psychological states on periodontitis severity and oral health-related quality of life. J Oral Sci. 2021; 64(1):1-5. DOI: 10.2334/josnusd.21-0267. View

12.

Ganesan S, Vazana S, Stuhr S . Waistline to the gumline: Relationship between obesity and periodontal disease-biological and management considerations. Periodontol 2000. 2021; 87(1):299-314. DOI: 10.1111/prd.12390. View

13.

Arias-Bujanda N, Regueira-Iglesias A, Balsa-Castro C, Nibali L, Donos N, Tomas I . Accuracy of single molecular biomarkers in saliva for the diagnosis of periodontitis: A systematic review and meta-analysis. J Clin Periodontol. 2019; 47(1):2-18. DOI: 10.1111/jcpe.13202. View

14.

Yadalam P, Kalaivani V, Fageeh H, Ibraheem W, Al-Ahmari M, Khan S . Future Drug Targets in Periodontal Personalised Medicine-A Narrative Review. J Pers Med. 2022; 12(3). PMC: 8955099. DOI: 10.3390/jpm12030371. View

15.

Jia R, Zhang Y, Wang Z, Hu B, Wang Z, Qiao H . Association between lipid metabolism and periodontitis in obese patients: a cross-sectional study. BMC Endocr Disord. 2023; 23(1):119. PMC: 10210456. DOI: 10.1186/s12902-023-01366-7. View

16.

Kwon T, Lamster I, Levin L . Current Concepts in the Management of Periodontitis. Int Dent J. 2021; 71(6):462-476. PMC: 9275292. DOI: 10.1111/idj.12630. View

17.

Ozcan E, Saygun N, Serdar M, Kurt N . Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation. Clin Oral Investig. 2014; 19(4):921-8. DOI: 10.1007/s00784-014-1308-0. View

18.

Verhulst M, Teeuw W, Bizzarro S, Muris J, Su N, Nicu E . A rapid, non-invasive tool for periodontitis screening in a medical care setting. BMC Oral Health. 2019; 19(1):87. PMC: 6533660. DOI: 10.1186/s12903-019-0784-7. View

19.

Anjum S, Rajasekar A . Assessment of independent variables of periodontal disease among selected South Indian population. J Adv Pharm Technol Res. 2023; 13(Suppl 1):S288-S292. PMC: 9836125. DOI: 10.4103/japtr.japtr_172_22. View

20.

Dakroub A, Nasser S, Kobeissy F, Yassine H, Orekhov A, Sharifi-Rad J . Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases. J Cell Physiol. 2021; 236(9):6282-6296. DOI: 10.1002/jcp.30345. View